Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Impedimed Limited ( (AU:IPD) ).
ImpediMed Limited has released details for shareholders on how to participate in its upcoming Extraordinary General Meeting scheduled for 11 June 2026 in Sydney. The company has provided an online meeting guide outlining technical requirements, including supported web browsers and the need for shareholder or proxy identification details to attend and vote remotely.
The notice underscores ImpediMed’s ongoing use of hybrid or online meeting formats to facilitate investor engagement and corporate governance processes. By clarifying access procedures and voting credentials in advance, the company aims to ensure orderly shareholder participation and compliance with market expectations around transparency and accountability.
The most recent analyst rating on (AU:IPD) stock is a Buy with a A$0.02 price target. To see the full list of analyst forecasts on Impedimed Limited stock, see the AU:IPD Stock Forecast page.
More about Impedimed Limited
ImpediMed Limited is an Australian medical technology company listed on the ASX under the ticker IPD. It develops and commercialises bioimpedance-based devices and related services used in clinical settings, focusing on measurement and monitoring solutions for healthcare providers and patients.
Average Trading Volume: 3,581,459
Technical Sentiment Signal: Sell
Current Market Cap: A$17.54M
See more data about IPD stock on TipRanks’ Stock Analysis page.